TAG:
laboratory association
“Here’s to Plain Talk and Clear Understanding!”
By R. Lewis Dark | From the Volume XV No. 1 – January 21, 2008 Issue
“WELL, SIR, HERE’S TO PLAIN TALK AND CLEAR UNDERSTANDING.” That’s a well-known line in the classic 1941 detective movie, “The Maltese Falcon.” It’s spoken by the Kasper Gutman character, played by Sidney Greenstreet, to San Francisco private eye, Sam Spade, played by Humphrey Bogart. Gu…
Labs Face “Coercive” Bid, Not Competitive Bidding
By Robert Michel | From the Volume XV No. 1 – January 21, 2008 Issue
CEO SUMMARY: In the weeks since the December 5 bidders’ conference in San Diego, where Medicare officials took the wraps off the complete requirements for the Laboratory Bidding Demonstration Project, the Clinical Laboratory Coalition has begun to consider strategies to delay or cancel …
Speculating On How Labs Might Respond to Demo
By Robert Michel | From the Volume XIV No. 18 – December 31, 2007 Issue
CEO SUMMARY: Statements and actions by CMS officials responsible for the laboratory competitive bidding demonstration project reveal the likelihood that they are using it as a Trojan Horse. While talking about implementation of a three-year demonstration project in the San Diego MSA, CMS …
August 27, 2007 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIV No. 12 – August 27, 2007 Issue
Something different is happening when the Associated Press does a story about how the American Clinical Laboratory Association (ACLA), a lab industry trade group, has spent money lobbying Congress. The Associated Press used federal records to confirm that ACLA, paid …
Intense Competition for Market Share in New York
By R. Lewis Dark | From the Volume XIV No. 10 – July 16, 2007 Issue
ONE OF THE MOST TURBULENT MARKETS FOR LAB SERVICES TODAY is New York City and the Tri-State area of New York, New Jersey, and Connecticut. This is ground zero in the fight for market share between Quest Diagnostics Incorporated and Laboratory Corporation of America a…
Exclusive Lab Contracts Have Consequences
By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue
CEO SUMMARY: During the past seven months, competition in the Northeast has intensified. Decisions by UnitedHealth and Aetna to exclude a national laboratory from their respective provider panels has forced many physicians to reconsider their choice of laboratory provider—creating an op…
ACLA Prepares to Tackle Tough Lab Industry Issues
By Robert Michel | From the Volume XIV No. 7 – May 14, 2007 Issue
CEO SUMMARY: At its annual meeting last month, the American Clinical Laboratory Association (ACLA) rolled out a new campaign to educate Congress, government and private payers, and the American public about the value of laboratory testing. Called “Results for Life,” the campaign is a …
Implementation Date Passes on Medicare Competitive Bid Project
By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue
YESTERDAY, APRIL 1, WAS THE DAY that the Centers for Medicare & Medicaid (CMS) was scheduled to implement the first sites for the Medicare Clinical Laboratory Services Competitive Bidding Demonstration project. It was good news for the laboratory industry that the day passed with…
Lab Competitive Bidding Project Slated For Jan. 1
By Robert Michel | From the Volume XIII No. 11 – August 14, 2006 Issue
CEO SUMMARY: In a rather quiet fashion, Medicare officials have disclosed timetable dates for implementing the laboratory competitive bidding demonstration mandated by the 2003 Medicare spending bill. Medicare intends to announce the names of participating laboratories by January 1, 2007….
Lab MUEs Reconsidered, CMS Changes Course
By Robert Michel | From the Volume XIII No. 8 – June 12, 2006 Issue
CEOSUMMARY: It may bear are moment of common sense. Last month, Medicare officials stated their intent to exclude clinical laboratory and anatomic pathology CPT codes from the “Phase One” implementation of Medically Unbelievable Edits (MUEs). It is a positive step, and comes in respon…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized